Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Cancer Research UK
Cancer Research UK
Activities:
Research & Development
X
LinkedIn
Trending Articles
Samsung Biologics signs $1.24bn biopharma manufacturing deal with Asian pharmaceutical giant
The CDMO will work with the client until the end of 2037, and will use its South Korean biomanufacturing site to serve them
Bespak and H&T Presspart announce availability of GMP pilot line for climate-friendly pMDIs
Filling line is on track to supply clinical trial batches utilising climate-friendly propellants HFA-152a and HFO-1234ze
Astellas' Vyloytm plus chemo gains FDA approval for gastric adenocarcinoma
The drug is the first CLDN18.2 targeted therapy to be approved in the US, and can further extend a patient's PFS and OS compared with chemotherapy alone
Axol Bioscience boosts its iPSC bioassay offering with Phenocell acquisition
The acquisition will extend Axol's range of iPSC-derived cell lines, including skin and retinal cells — while also expanding its drug discovery services
How AI and GenAI will revolutionise the healthcare industry
Artificial intelligence — and particularly its newest iteration, generative artificial intelligence (GenAI) — could bring significant changes to the way we live, work and...
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Study demonstrates way to target hard-to-treat cancer mutation
The study was funded by Cancer Research UK and Wellcome
Research & Development
Aptamer and Cancer Research UK collaborate for drug discovery
The project will explore aptamers as therapeutic agents for the treatment of Chronic Myelomonocytic Leukaemia and other myeloid malignancies
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Research & Development
Oesophageal cancer genes leads to new drug targets
Mutations that cause oesophageal adenocarcinoma have been mapped unveiling that more than half could be targeted by drugs currently in trials for other cancer types.
Regulatory
Clinical trial launches to develop breath test for multiple cancers
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage
Research & Development
Cancer Research UK and AstraZeneca launch functional genomics centre
The centre will be a dedicated resource for AstraZeneca and Cancer Research UK’s academics and alliance partners working at all stages of translational research
Regulatory
Patients could lose out on life-saving treatments
Limited access to novel therapies could hinder effective personalised cancer treatment in the UK, says GlobalData
Subscribe now